US equities
|
NVDA
$239.24
▲+0.14%
MU
$1,045.56
▼-1.73%
SPCX
$171.92
▲+0.49%
AMD
$649.42
▲+2.80%
MRVL
$287.01
▲+5.81%
AVGO
$375.81
▲+3.67%
INTC
$112.50
▼-3.18%
MSFT
$529.30
▲+0.78%
NVDA
$239.24
▲+0.14%
MU
$1,045.56
▼-1.73%
SPCX
$171.92
▲+0.49%
AMD
$649.42
▲+2.80%
MRVL
$287.01
▲+5.81%
AVGO
$375.81
▲+3.67%
INTC
$112.50
▼-3.18%
MSFT
$529.30
▲+0.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
(CSE:
MLCO
)
0.0700
+0.0100 (+16.67%)
Delayed Quote
Updated: 1:06 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MLCO
The More Life Company Advancing U.S. Compounded Pharmaceutical Commercialization Pathway for Quicksome™
Today 8:45 EDT
From
THE MORE LIFE COMPANY CORP.
Via
Business Wire
The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study
September 22, 2026
From
The More Life Company Corp.
Via
Business Wire
The More Life Company Reports Positive Third-Party Agrarius Potato Trial Results in Brazil
September 15, 2026
From
The More Life Company Corp.
Via
Business Wire
The More Life Company Corp. Announces New U.S. Trading Symbol
August 20, 2026
From
The More Life Company Corp.
Via
Business Wire
